Trial Outcomes & Findings for Blue Light Intraocular Lenses (IOLs) and Photostress (NCT NCT00710996)
NCT ID: NCT00710996
Last Updated: 2010-02-02
Results Overview
The time necessary to recover function (e.g., contrast discrimination) following exposure to a bright glare source.
COMPLETED
58 participants
3 months
2010-02-02
Participant Flow
Patients with existing bilateral intraocular lenses (IOLs) of given type, age-matched patients with normal vision and no cataract surgery.
Subjects eligibility was determined at the preoperative visit. All subjects met inclusion/exclusion criteria.
Participant milestones
| Measure |
AcrySof Natural Intraocular Lens
AcrySof Natural Intraocular Lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SN"
|
AcrySof Clear Intraocular Lens
AcrySof clear intraocular lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SA"
|
Phakic Patients
Phakic patients - Age matched patients who have not had cataract surgery
|
|---|---|---|---|
|
Overall Study
STARTED
|
17
|
20
|
21
|
|
Overall Study
COMPLETED
|
16
|
16
|
21
|
|
Overall Study
NOT COMPLETED
|
1
|
4
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Blue Light Intraocular Lenses (IOLs) and Photostress
Baseline characteristics by cohort
| Measure |
AcrySof Natural Intraocular Lens
n=17 Participants
AcrySof Natural Intraocular Lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SN"
|
AcrySof Clear Intraocular Lens
n=20 Participants
AcrySof clear intraocular lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SA"
|
Phakic Patients
n=21 Participants
Phakic patients - Age matched patients who have not had cataract surgery
|
Total
n=58 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
0 Participants
n=483 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
2 Participants
n=93 Participants
|
2 Participants
n=4 Participants
|
3 Participants
n=27 Participants
|
7 Participants
n=483 Participants
|
|
Age, Categorical
>=65 years
|
15 Participants
n=93 Participants
|
18 Participants
n=4 Participants
|
18 Participants
n=27 Participants
|
51 Participants
n=483 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=93 Participants
|
13 Participants
n=4 Participants
|
10 Participants
n=27 Participants
|
34 Participants
n=483 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=93 Participants
|
7 Participants
n=4 Participants
|
11 Participants
n=27 Participants
|
24 Participants
n=483 Participants
|
PRIMARY outcome
Timeframe: 3 monthsThe time necessary to recover function (e.g., contrast discrimination) following exposure to a bright glare source.
Outcome measures
| Measure |
AcrySof Natural Intraocular Lens
n=16 Participants
AcrySof Natural Intraocular Lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SN"
|
AcrySof Clear Intraocular Lens
n=16 Participants
AcrySof clear intraocular lens (IOL) - Patients with previous bilateral implant of any Alcon lens model starting with the letters "SA"
|
Phakic Patients
n=21 Participants
Phakic patients - Age matched patients who have not had cataract surgery
|
|---|---|---|---|
|
Photostress Recovery Time in Seconds.
|
36 seconds
Standard Deviation 25.94
|
41.46 seconds
Standard Deviation 25.94
|
24.88 seconds
Standard Deviation 15.45
|
Adverse Events
AcrySof Natural Intraocular Lens
AcrySof Clear Intraocular Lens
Phakic Patients
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor's prior written agreement.
- Publication restrictions are in place
Restriction type: OTHER